The Cible Skin Story

A vision and a family legacy to develop the first skin longevity science.

Our founders, Drs. Aknin father and son, developed 1-LGVTY®, the world’s first technology that allows for the rejuvenation of the biological age of the skin…

Les docteurs Aknin

Cible Skin is a story of vision and family legacy led by Dr. Joël Aknin, a renowned plastic surgeon, and his son, Dr. Raphaël Aknin, a pharmacy expert in skin immunology.

Les docteurs Aknin

Over ten years ago, this scientific adventure was born from a shared ambition: to reverse cellular aging and rejuvenate the biological age of the skin.

In the laboratories of a biotechnology company, Dr. Raphaël Aknin, then a research director, embarked on the development of regenerative treatments to strengthen and repair the skin of patients undergoing chemotherapy.

Scientifique en recherche

By exploring the link between the skin’s immune system and cellular regeneration, he made a major discovery: activating the skin’s immune system can reduce its biological aging.

Back in France, he shared this discovery with his father. Together, by combining their expertise in aesthetic surgery and skin immunology, they created the first science of skin longevity.

Structure moléculaire

From this combination of expertise, Cible Skin was born: the exceptional scientific promise to rejuvenate the biological age of the skin.

Les docteurs Aknin Scientifique en recherche Structure moléculaire

The Longevity Skincare.
For skin where time becomes the best ally.

By enhancing the skin’s immune competence through this groundbreaking scientific approach, Cible Skin not only combats the visible signs of aging but also reverses the biological markers of old age, rejuvenating the skin’s biological age.

Ampoule en verre ambré remplie

After 10 years of research, Dr. Aknin has developed the world’s first patented cosmetic technology capable of activating the skin’s immune system, enhancing skin longevity.

Strengthening the skin’s immune system is the key to longevity.

Flacons Cible Skin sur fond nuageux
A biotechnological breakthrough that redefines modern cosmetology.

1-LGVTY®

Our patented 1-LGVTY® technology rejuvenates the biological age of the skin by targeting the three cellular stresses responsible for skin aging: inflammatory, oxidative, and microbiological stress.
Flacon Cible Skin

Comparison of skin explants from the clinical study

Stress situation vs. 1-LGVTY + stress situation

The actions of 1-LGVTY on biomarkers of skin longevity:

Une technologie brevetée qui cible les paramètres cutanés essentiels à la longévité de la peau.

Woman - Phototype III - 60 years old
Avant
Après
Spots: melanin reduction

. It supports the regulation of melanin synthesis to accompany task-oriented protocols and improve skin tone uniformity over time.

Réduction de mélanine
Wrinkles: collagen synthesis

. It supports collagen and elastin markers to accompany the remodeling dynamics induced by the procedure and strengthen skin firmness over time.

Synthèse de collagène
Tightness: Hyaluronic acid synthesis

. It supports hyaluronic acid markers and overall skin performance to promote a smoother surface and refined skin quality.

Synthèse d’acide hyaluronique

The Cible Skin Foundation funds and develops research in the sciences that enhance skin longevity

The aim of the Cible Skin Foundation is to develop the next innovations that will protect and heal the skin from any aggressions and diseases.

Contact a Skinconsultant

The Cible Skin Skinconsultants are available for any information from Monday to Saturday, from 10:00 AM to 7:00 PM.

Contact us via WhatsApp via Instagram or by Email.

Votre panier

Free shipping in mainland France
for orders over €150 online

Votre panier est vide.
Commencez par ajouter des produits.

Our Recommendations

Spinner
Discussion instantanée
Discussion instantanée
Un ambassadeur Cible Skin est disponible pour vous accompagner lors de votre expérience